創薬・診断におけるディープラーニングの世界市場レポート 2025年

創薬・診断におけるディープラーニング市場規模は、今後数年間で飛躍的な成長が見込まれます。2029年の年間平均成長率（CAGR）は28.5%で288億2,000万米ドルに成長します。予測期間の成長は、診断精度の向上、ハイテク企業と製薬企業間の協力関係の拡大、モデルの透明性を高めるための説明可能なAI（xai）の進歩、リアルワールドエビデンス（RWE）の重視の高まり、新興市場への進出に起因すると考えられます。予測期間における主な動向としては、AI技術の採用、計算能力の向上、ビッグデータの統合、新規ディープラーニングアーキテクチャの開発、AI用クラウドベースプラットフォームの拡大などが挙げられます。

個別化医療に対する需要の高まりは、創薬と診断におけるディープラーニング市場の成長を促進すると予想されます。個別化医療は、個人の遺伝的、環境的、生活習慣的要因に基づいて治療や介入をカスタマイズし、効果を向上させ副作用を軽減します。この需要は、個々の患者プロファイルに合わせたより正確な治療を可能にするゲノミクスとデータ分析の進歩によって促進されています。ディープラーニングは、複雑な生物学的データを分析して独自のバイオマーカーを発見し、患者の反応をより正確に予測することで、個別化医療を強化します。例えば、2024年2月、個別化医療連合（Personalized Medicine Coalition）は、FDAが2023年に希少疾患に対する新たな個別化治療を16件承認し、2022年の6件から増加したと報告しました。このような個別化医療への関心の高まりが、創薬・診断におけるディープラーニングの拡大を後押ししています。

ディープラーニングによる創薬・診断市場の主要プレーヤーは、複雑なタスクやAIアプリケーションのパフォーマンスと効率性の向上を通じてイノベーションを後押しするため、スーパーコンピュータなどのハイパフォーマンス・コンピューティング技術の進歩に注力しています。スーパーコンピューターの改良は、複雑なデータ解析やシミュレーションを高速化することでディープラーニングを促進し、医薬品候補の迅速な特定や診断精度の向上に役立ちます。例えば、米国のIT企業ヒューレット・パッカード・エンタープライズは2022年11月、HPE Cray EXおよびHPE Cray XDスーパーコンピューターを発表しました。これらのシステムは、創薬や疾病治療の迅速化を目指し、よりコンパクトでコスト効率の高い設計で、強力なパフォーマンスとスケーラブルなAI機能を提供します。これらのシステムにより、研究者や製薬研究所は化学的相互作用についてより深い洞察を得ることができ、難病や新興疾患に対する新たな治療法の開発が促進されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界創薬・診断におけるディープラーニング PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の創薬・診断におけるディープラーニング市場：成長率分析
• 世界の創薬・診断におけるディープラーニング市場の実績：規模と成長, 2019-2024
• 世界の創薬・診断におけるディープラーニング市場の予測：規模と成長, 2024-2029, 2034F
• 世界創薬・診断におけるディープラーニング総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の創薬・診断におけるディープラーニング市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 創薬
• 診断
• 法医学的介入
• その他のタイプ
• 世界の創薬・診断におけるディープラーニング市場薬剤の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 低分子医薬品
• 生物学的製剤
• 世界の創薬・診断におけるディープラーニング市場：最終用途産業別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 製薬会社
• バイオテクノロジー企業
• 契約調査機関（CRO）
• ヘルスケア情報技術（IT）
• 世界の創薬・診断におけるディープラーニング市場、創薬のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ターゲット識別
• 薬物検査
• リード最適化
• 予測モデリング
• 世界の創薬・診断におけるディープラーニング市場、診断のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 医療画像解析
• ゲノムデータ解釈
• 病気検出アルゴリズム
• パーソナライズ医療
• 世界の創薬・診断におけるディープラーニング市場法医学的介入の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• デジタル病理学
• 法医学的DNA分析
• 毒性スクリーニング
• 犯罪現場の再現
• 世界の創薬・診断におけるディープラーニング市場、その他のタイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• バイオマーカーの発見
• ヘルスケアにおける予測分析
• 患者データ管理システム

第7章 地域別・国別分析

• 世界の創薬・診断におけるディープラーニング市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の創薬・診断におけるディープラーニング市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 創薬・診断におけるディープラーニング市場：競合情勢
• 創薬・診断におけるディープラーニング市場：企業プロファイル
  • Google Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Microsoft Corporation Overview, Products and Services, Strategy and Financial Analysis
  • International Business Machines Corporation（IBM）Overview, Products and Services, Strategy and Financial Analysis
  • NVIDIA Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Zebra Medical Vision Ltd Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Tempus Labs Inc.
• Nanostring Technologies Inc.
• Owkin Inc.
• Insilico Medicine Inc.
• SOPHiA GENETICS SA
• Qureai Technologies Pvt Ltd
• H2Oai Inc.
• Arterys Inc.
• Deep Genomics Inc.
• GNS Healthcare Inc.
• MedAware Systems Inc.
• PathAI Inc.
• Kheiron Medical Technologies Ltd
• CureMetrix Inc.
• OncoImmunity AS

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 創薬・診断におけるディープラーニング市場2029：新たな機会を提供する国
• 創薬・診断におけるディープラーニング市場2029：新たな機会を提供するセグメント
• 創薬・診断におけるディープラーニング市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Deep learning in drug discovery and diagnostics involves utilizing advanced neural networks and artificial intelligence (AI) to interpret complex biological and chemical data, allowing for the prediction of drug interactions, identification of disease patterns, and advancement of personalized medicine. This approach enhances drug discovery and diagnostics by increasing prediction accuracy, automating data processing, and facilitating personalized treatments through sophisticated data analysis.

Key applications of deep learning in this field include drug discovery, diagnostics, forensic interventions, and more. In drug discovery, deep learning algorithms analyze biological data to predict the effectiveness of drug compounds, accelerating the identification of potential candidates and side effects earlier in the research process. These drugs include small molecules and biologics, with end-use industries ranging from pharmaceutical and biotechnology companies to contract research organizations (CROs) and healthcare information technology (IT).

The deep learning in drug discovery and diagnostics market research report is one of a series of new reports from The Business Research Company that provides deep learning in drug discovery and diagnostics market statistics, including deep learning in drug discovery and diagnostics industry global market size, regional shares, competitors with a deep learning in drug discovery and diagnostics market share, detailed deep learning in drug discovery and diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the deep learning in drug discovery and diagnostics industry. This deep learning in drug discovery and diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The deep learning in drug discovery and diagnostics market size has grown exponentially in recent years. It will grow from $8.21 $ billion in 2024 to $10.58 $ billion in 2025 at a compound annual growth rate (CAGR) of 28.8%. The growth in the historic period can be attributed to increased investment in AI research, growing demand for personalized medicine, increased funding from public and private sectors, rise in chronic diseases and complex conditions, and growing adoption of electronic health records.

The deep learning in drug discovery and diagnostics market size is expected to see exponential growth in the next few years. It will grow to $28.82 $ billion in 2029 at a compound annual growth rate (CAGR) of 28.5%. The growth in the forecast period can be attributed to improved diagnostic accuracy, growing collaboration between tech companies and pharmaceutical firms, progress in explainable AI (xai) for better model transparency, increased emphasis on real-world evidence (RWE), and expansion into emerging markets. Major trends in the forecast period include the adoption of AI technologies, advancements in computational power, integration of big data, development of novel deep learning architectures, and expansion of cloud-based platforms for AI.

The increasing demand for personalized medicine is expected to drive the growth of the deep learning market in drug discovery and diagnostics. Personalized medicine customizes treatment and interventions based on an individual's genetic, environmental, and lifestyle factors to improve effectiveness and reduce side effects. This demand is fueled by advancements in genomics and data analytics, which allow for more precise treatments tailored to individual patient profiles. Deep learning enhances personalized medicine by analyzing complex biological data to discover unique biomarkers and predict patient responses more accurately. For example, in February 2024, the Personalized Medicine Coalition reported that the FDA approved 16 new personalized therapies for rare diseases in 2023, up from six in 2022. This growing interest in personalized medicine is driving the expansion of deep learning in drug discovery and diagnostics.

Key players in the deep learning drug discovery and diagnostics market are focusing on advancing high-performance computing technologies, such as supercomputers, to boost innovation through enhanced performance and efficiency in complex tasks and AI applications. Improvements in supercomputers facilitate deep learning by accelerating complex data analysis and simulations, which helps in identifying drug candidates more quickly and improving diagnostic accuracy. For instance, in November 2022, Hewlett-Packard Enterprise, a US-based IT company, launched the HPE Cray EX and HPE Cray XD supercomputers. These systems offer powerful performance and scalable AI capabilities in a more compact and cost-effective design, aimed at expediting drug discovery and disease treatment. They enable researchers and pharmaceutical labs to gain deeper insights into chemical interactions, which promotes the development of new therapies for both challenging and emerging diseases.

In February 2024, Ginkgo Bioworks Holdings Inc., a US-based biotech company specializing in genetic engineering, acquired key assets from Reverie Labs for an undisclosed sum. This acquisition includes Reverie's infrastructure and software for training large-scale AI foundation models, which Ginkgo intends to leverage to enhance its AI and machine learning (ML)-driven discovery services and accelerate the development of next-generation biological foundation models. Reverie Labs Inc. is a US-based company that has developed and utilized AI and ML tools to expedite drug discovery.

Major companies operating in the deep learning in drug discovery and diagnostics market are Google Inc., Microsoft Corporation, International Business Machines Corporation, NVIDIA Corporation, Zebra Medical Vision Ltd, Tempus Labs Inc., Nanostring Technologies Inc., Owkin Inc., Insilico Medicine Inc., SOPHiA GENETICS SA, Qureai Technologies Pvt Ltd, H2Oai Inc., Arterys Inc., Deep Genomics Inc., GNS Healthcare Inc., MedAware Systems Inc., PathAI Inc., Kheiron Medical Technologies Ltd, CureMetrix Inc., OncoImmunity AS, Proscia Inc., BenevolentAI Ltd, BioXcel Therapeutics Inc.

North America was the largest region in the deep learning in drug discovery and diagnostics market in 2023. The regions covered in the deep learning in drug discovery and diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the deep learning in drug discovery and diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The deep learning in drug discovery and diagnostics market consists of revenues earned by entities by providing services such as developing and integrating deep learning algorithms, analyzing large-scale biological and chemical data, offering software solutions and platforms, and consulting on AI-driven drug discovery and diagnostic strategies. The market value includes the value of related goods sold by the service provider or included within the service offering. The deep learning in drug discovery and diagnostics market also includes sales of software platforms and tools, machine learning frameworks, data analytics solutions, cloud-based computing services, hardware accelerators, and AI-driven diagnostic devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Deep Learning In Drug Discovery And Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on deep learning in drug discovery and diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for deep learning in drug discovery and diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The deep learning in drug discovery and diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Drug Discovery; Diagnostics; Forensic Interventions; Other Types
• 2) By Drug Type: Small Molecule Drugs; Biologics Drugs
• 3) By End Use Industry: Pharmaceutical Companies; Biotechnology Companies; Contract Research Organizations (CROs); Healthcare Information Technology (IT)
• Subsegments:
• 1) By Drug Discovery: Target Identification; Drug Screening; Lead Optimization; Predictive Modeling
• 2) By Diagnostics: Medical Imaging Analysis; Genomic Data Interpretation; Disease Detection Algorithms; Personalized Medicine
• 3) By Forensic Interventions: Digital Pathology; Forensic DNA Analysis; Toxicology Screening; Crime Scene Reconstruction
• 4) By Other Types: Biomarker Discovery; Predictive Analytics in Healthcare; Patient Data Management Systems
• Companies Mentioned: Google Inc.; Microsoft Corporation; International Business Machines Corporation; NVIDIA Corporation; Zebra Medical Vision Ltd
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Deep Learning In Drug Discovery And Diagnostics Market Characteristics

3. Deep Learning In Drug Discovery And Diagnostics Market Trends And Strategies

4. Deep Learning In Drug Discovery And Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Deep Learning In Drug Discovery And Diagnostics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Deep Learning In Drug Discovery And Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Deep Learning In Drug Discovery And Diagnostics Market Growth Rate Analysis
• 5.4. Global Deep Learning In Drug Discovery And Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Deep Learning In Drug Discovery And Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Deep Learning In Drug Discovery And Diagnostics Total Addressable Market (TAM)

6. Deep Learning In Drug Discovery And Diagnostics Market Segmentation

• 6.1. Global Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug Discovery
• Diagnostics
• Forensic Interventions
• Other Types
• 6.2. Global Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Small Molecule Drugs
• Biologics Drugs
• 6.3. Global Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical Companies
• Biotechnology Companies
• Contract Research Organizations (CROs)
• Healthcare Information Technology (IT)
• 6.4. Global Deep Learning In Drug Discovery And Diagnostics Market, Sub-Segmentation Of Drug Discovery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Target Identification
• Drug Screening
• Lead Optimization
• Predictive Modeling
• 6.5. Global Deep Learning In Drug Discovery And Diagnostics Market, Sub-Segmentation Of Diagnostics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medical Imaging Analysis
• Genomic Data Interpretation
• Disease Detection Algorithms
• Personalized Medicine
• 6.6. Global Deep Learning In Drug Discovery And Diagnostics Market, Sub-Segmentation Of Forensic Interventions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Digital Pathology
• Forensic DNA Analysis
• Toxicology Screening
• Crime Scene Reconstruction
• 6.7. Global Deep Learning In Drug Discovery And Diagnostics Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biomarker Discovery
• Predictive Analytics in Healthcare
• Patient Data Management Systems

7. Deep Learning In Drug Discovery And Diagnostics Market Regional And Country Analysis

• 7.1. Global Deep Learning In Drug Discovery And Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Deep Learning In Drug Discovery And Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Deep Learning In Drug Discovery And Diagnostics Market

• 8.1. Asia-Pacific Deep Learning In Drug Discovery And Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Deep Learning In Drug Discovery And Diagnostics Market

• 9.1. China Deep Learning In Drug Discovery And Diagnostics Market Overview
• 9.2. China Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Deep Learning In Drug Discovery And Diagnostics Market

• 10.1. India Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Deep Learning In Drug Discovery And Diagnostics Market

• 11.1. Japan Deep Learning In Drug Discovery And Diagnostics Market Overview
• 11.2. Japan Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Deep Learning In Drug Discovery And Diagnostics Market

• 12.1. Australia Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Deep Learning In Drug Discovery And Diagnostics Market

• 13.1. Indonesia Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Deep Learning In Drug Discovery And Diagnostics Market

• 14.1. South Korea Deep Learning In Drug Discovery And Diagnostics Market Overview
• 14.2. South Korea Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Deep Learning In Drug Discovery And Diagnostics Market

• 15.1. Western Europe Deep Learning In Drug Discovery And Diagnostics Market Overview
• 15.2. Western Europe Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Deep Learning In Drug Discovery And Diagnostics Market

• 16.1. UK Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Deep Learning In Drug Discovery And Diagnostics Market

• 17.1. Germany Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Deep Learning In Drug Discovery And Diagnostics Market

• 18.1. France Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Deep Learning In Drug Discovery And Diagnostics Market

• 19.1. Italy Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Deep Learning In Drug Discovery And Diagnostics Market

• 20.1. Spain Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Deep Learning In Drug Discovery And Diagnostics Market

• 21.1. Eastern Europe Deep Learning In Drug Discovery And Diagnostics Market Overview
• 21.2. Eastern Europe Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Deep Learning In Drug Discovery And Diagnostics Market

• 22.1. Russia Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Deep Learning In Drug Discovery And Diagnostics Market

• 23.1. North America Deep Learning In Drug Discovery And Diagnostics Market Overview
• 23.2. North America Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Deep Learning In Drug Discovery And Diagnostics Market

• 24.1. USA Deep Learning In Drug Discovery And Diagnostics Market Overview
• 24.2. USA Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Deep Learning In Drug Discovery And Diagnostics Market

• 25.1. Canada Deep Learning In Drug Discovery And Diagnostics Market Overview
• 25.2. Canada Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Deep Learning In Drug Discovery And Diagnostics Market

• 26.1. South America Deep Learning In Drug Discovery And Diagnostics Market Overview
• 26.2. South America Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Deep Learning In Drug Discovery And Diagnostics Market

• 27.1. Brazil Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Deep Learning In Drug Discovery And Diagnostics Market

• 28.1. Middle East Deep Learning In Drug Discovery And Diagnostics Market Overview
• 28.2. Middle East Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Deep Learning In Drug Discovery And Diagnostics Market

• 29.1. Africa Deep Learning In Drug Discovery And Diagnostics Market Overview
• 29.2. Africa Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Deep Learning In Drug Discovery And Diagnostics Market Competitive Landscape And Company Profiles

• 30.1. Deep Learning In Drug Discovery And Diagnostics Market Competitive Landscape
• 30.2. Deep Learning In Drug Discovery And Diagnostics Market Company Profiles
  • 30.2.1. Google Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Microsoft Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. International Business Machines Corporation (IBM) Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. NVIDIA Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Zebra Medical Vision Ltd Overview, Products and Services, Strategy and Financial Analysis

31. Deep Learning In Drug Discovery And Diagnostics Market Other Major And Innovative Companies

• 31.1. Tempus Labs Inc.
• 31.2. Nanostring Technologies Inc.
• 31.3. Owkin Inc.
• 31.4. Insilico Medicine Inc.
• 31.5. SOPHiA GENETICS SA
• 31.6. Qureai Technologies Pvt Ltd
• 31.7. H2Oai Inc.
• 31.8. Arterys Inc.
• 31.9. Deep Genomics Inc.
• 31.10. GNS Healthcare Inc.
• 31.11. MedAware Systems Inc.
• 31.12. PathAI Inc.
• 31.13. Kheiron Medical Technologies Ltd
• 31.14. CureMetrix Inc.
• 31.15. OncoImmunity AS

32. Global Deep Learning In Drug Discovery And Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Deep Learning In Drug Discovery And Diagnostics Market

34. Recent Developments In The Deep Learning In Drug Discovery And Diagnostics Market

35. Deep Learning In Drug Discovery And Diagnostics Market High Potential Countries, Segments and Strategies

• 35.1 Deep Learning In Drug Discovery And Diagnostics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Deep Learning In Drug Discovery And Diagnostics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Deep Learning In Drug Discovery And Diagnostics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer